Profile data is unavailable for this security.
About the company
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
- Revenue in USD (TTM)31.37m
- Net income in USD-9.73m
- Incorporated1989
- Employees82.00
- LocationCryo-Cell International Inc700 BROOKER CREEK BLVD, SUITE 1800OLDSMAR 34677United StatesUSA
- Phone+1 (813) 749-2104
- Fax+1 (813) 855-4745
- Websitehttps://www.cryo-cell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiff Lexington Corp | 12.35m | -2.15m | 45.57m | 2.00 | -- | -- | -- | 3.69 | -0.0102 | -0.0109 | 0.0007 | 0.0058 | 0.7163 | -- | 1.32 | 6,173,760.00 | -8.97 | -52.27 | -23.24 | -- | 70.08 | 57.44 | -12.53 | -58.31 | -- | 1.13 | 0.4002 | -- | 21.45 | 49.15 | -1,701.81 | -- | -- | -- |
| Oncology Institute Inc | 324.24m | -67.88m | 50.11m | 800.00 | -- | 0.8753 | -- | 0.1546 | -0.9187 | -0.9187 | 4.39 | 0.7691 | 1.38 | 23.08 | 7.89 | 405,298.80 | -35.28 | -- | -40.88 | -- | 18.37 | 19.54 | -25.62 | -9.99 | 3.73 | -8.16 | 0.6036 | -- | 28.42 | 23.43 | -99,919.12 | -- | 45.68 | -- |
| Prenetics Global Ltd | 21.74m | -54.35m | 71.47m | 800.00 | -- | 0.346 | -- | 3.29 | -4.60 | -5.31 | 1.94 | 16.91 | 0.0768 | 3.37 | 0.9505 | -- | -19.92 | -- | -24.55 | -- | 40.61 | -- | -259.40 | -- | 2.29 | -5.92 | 0.0112 | -- | 65.17 | -- | 75.91 | -- | -- | -- |
| CRYO-CELL International, Inc. | 31.37m | -9.73m | 73.99m | 82.00 | -- | -- | -- | 2.36 | -1.18 | -1.18 | 3.77 | -1.25 | 0.4908 | 10.31 | 4.74 | 382,579.60 | -15.23 | 0.4686 | -21.73 | 0.7099 | 72.79 | 70.09 | -31.02 | 0.8133 | 0.449 | 5.93 | -- | -- | 3.32 | 1.41 | -443.57 | -- | 60.30 | -- |
| Burning Rock Biotech Ltd (ADR) | 74.46m | -90.56m | 82.38m | 786.00 | -- | 0.7745 | -- | 1.11 | -88.45 | -88.45 | 72.71 | 10.37 | 0.4091 | 1.75 | 3.57 | 94,728.47 | -49.76 | -37.09 | -66.95 | -45.29 | 67.59 | 70.02 | -121.63 | -123.88 | 3.09 | -- | 0.00 | -- | -4.58 | 20.81 | 32.69 | -- | -17.61 | -- |
| ProPhase Labs Inc | 44.38m | -16.78m | 97.49m | 113.00 | -- | 1.87 | -- | 2.20 | -0.9544 | -0.9544 | 2.53 | 2.74 | 0.4943 | 7.20 | 1.21 | 392,778.80 | -18.69 | 0.9106 | -23.53 | 1.12 | 36.59 | 50.32 | -37.81 | 0.9325 | 2.10 | -18.06 | 0.1521 | 665.78 | -63.81 | 27.59 | -190.90 | -- | 86.46 | -- |
| Holder | Shares | % Held |
|---|---|---|
| SFI Advisors LLCas of 31 Dec 2023 | 165.30k | 2.00% |
| MML Investors Services LLCas of 31 Mar 2024 | 111.04k | 1.34% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 92.94k | 1.12% |
| Geode Capital Management LLCas of 31 Dec 2023 | 20.95k | 0.25% |
| Cerity Partners LLCas of 31 Dec 2023 | 19.56k | 0.24% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 15.84k | 0.19% |
| Rowland Miller + Partners LLCas of 31 Mar 2024 | 14.43k | 0.17% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 12.04k | 0.15% |
| Northern Trust Global Investments Ltd.as of 31 Dec 2023 | 10.46k | 0.13% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 2.00k | 0.02% |
